One is that certain mutations of the RAS genes, notably HRAS codon 13 mutations previously reported in anaplastic thyroid cancer, and KRAS codon 61 in both PTC and PDTC, were not analyzed. The gene discussed is HRAS; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.